ProFrac reported Q4 2024 revenue of $455 million, down from $575 million in the prior quarter. The company posted a net loss of $102 million, reflecting adverse market conditions and lower activity levels. Adjusted EBITDA fell to $71 million, down from $135 million in Q3. The Stimulation Services segment remained the largest revenue contributor at $384 million. ProFrac expects market conditions to improve in 2025 with increased fleet deployment and better operational efficiency.
Revenue declined to $455 million from $575 million in Q3 due to pricing pressure and seasonal budget exhaustion.
Net loss widened to $102 million from $44 million in Q3, reflecting weaker market conditions.
Adjusted EBITDA dropped to $71 million from $135 million in Q3 as margins contracted.
Stimulation Services remained the largest segment, generating $384 million in revenue.
ProFrac anticipates improved market conditions in 2025 with increased fleet deployment and enhanced operational efficiencies.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance